Kingworld Medicines Group Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 415.300 million compared to CNY 292.948 million a year ago. Operating income was CNY 46.550 million compared to CNY 49.328 million a year ago. Net income was CNY 19.482 million compared to CNY 9.850 million a year ago. Basic earnings per share from continuing operations was CNY 0.0321 compared to CNY 0.016 a year ago.